Citations (8)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (4)
Rodolfo Villena, Paula Kriz, Myint Tin Tin Htar, Cindy Burman, Jamie Findlow, Paul Balmer & Luis Jodar. (2023) Real-world impact and effectiveness of MenACWY-TT. Human Vaccines & Immunotherapeutics 19:2.
Read now
Read now
Liping Huang, Sonya J. Snedecor, Paul Balmer & Amit Srivastava. (2022) Potential public health impact of a Neisseria meningitidis A, B, C, W, and Y pentavalent vaccine in the United States. Postgraduate Medicine 134:4, pages 341-348.
Read now
Read now
Timo Vesikari, Paula Peyrani, Chris Webber, Marie Van Der Wielen, Brigitte Cheuvart, Nathalie De Schrevel, Emmanuel Aris, Mark Cutler, Ping Li & John L. Perez. (2020) Ten-Year Antibody Persistence and Booster Response to MenACWY-TT Vaccine After Primary Vaccination at 1-10 Years of Age. Human Vaccines & Immunotherapeutics 16:6, pages 1280-1291.
Read now
Read now
Beatriz Quiambao, Paula Peyrani, Ping Li, Mark W. Cutler, Marie Van Der Wielen, John L. Perez & Chris Webber. (2020) Efficacy and safety of a booster dose of the meningococcal A, C, W, Y-tetanus toxoid conjugate vaccine administered 10 years after primary vaccination and long-term persistence of tetanus toxoid conjugate or polysaccharide vaccine. Human Vaccines & Immunotherapeutics 16:6, pages 1272-1279.
Read now
Read now
Articles from other publishers (4)
Charissa Fay Corazon Borja-Tabora, Paula Peyrani, Chris Webber, Marie Van der Wielen, Brigitte Cheuvart, Nathalie De Schrevel, Veronique Bianco, Emmanuel Aris, Mark Cutler, Ping Li & John L. Perez. (2020) A phase 2b/3b MenACWY-TT study of long-term antibody persistence after primary vaccination and immunogenicity and safety of a booster dose in individuals aged 11 through 55 years. BMC Infectious Diseases 20:1.
Crossref
Crossref
Chris Webber, Paula Peyrani, Paul Balmer & Lidia Serra. (2020) Persistence of bactericidal antibodies following primary and booster MenACWY-TT vaccination of toddlers: A review of clinical studies. Vaccine 38:27, pages 4236-4245.
Crossref
Crossref
Jamie Findlow & Markus Knuf. (2019) Immunogenicity and safety of meningococcal group A, C, W and Y tetanus toxoid conjugate vaccine: review of clinical and real-world evidence. Future Microbiology 14:7, pages 563-580.
Crossref
Crossref
Lidia C. Serra, Laura J. York, Paul Balmer & Chris Webber. (2018) Meningococcal Group A, C, W, and Y Tetanus Toxoid Conjugate Vaccine: A Review of Clinical Data in Adolescents. Journal of Adolescent Health 63:3, pages 269-279.
Crossref
Crossref